Dermatomyositis: An Acute Flare and Current Treatments.

Funding Source

National Institute on Minority Health and Health Disparities

Grant Number



College of Pharmacy

Document Type


Publication Date



The purpose of this case report is to assess and review the literature to determine the frequency of occurrence of dermatomyositis (DM). Dermatomyositis is a rare autoimmune condition that disproportionately affects adolescence and pediatric patients. The symptomatology experienced in this condition includes but not limited to fatigue, reduced mobility, and dysphagia. Symptoms of dysphonia and dyspnea have been reported due to weakened esophageal and respiratory muscle. Another major complication seen in DM is calcinosis. Calcinosis is a calcium deposit on soft tissue. This is mostly been attributed to late diagnosis or use of ineffective treatment regimen. Systemic corticosteroid is the first-line treatment for DM; however, other agents such as anti-malaria, IVIG, and immunosuppressive therapies have been used successfully.


DOI: 10.1177/1179547619855370

Funding text

FunDIng: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was support partially by the Grant, 5 S21 MD 000100-12, from the National Institute on Minority Health and Health Disparities (NIMHD), and D34HP00006-28-0 from Health Resource and Service Administration of DHHS. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the NIH, NIMHD, HRSA or DHHS.